£1 million award for BactiVac network to continue supporting development of bacterial vaccines

  22 February 2023

Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease. 

BactiVac, the Bacterial Vaccines Network, has secured £1 million of funding from Wellcome to accelerate the development of bacterial vaccines and combat the threat of antimicrobial resistance (AMR).

Further reading: University of Birmingham
Author(s): University of Birmingham
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!